Literature DB >> 29902482

Improving the generation and selection of virtual populations in quantitative systems pharmacology models.

Theodore R Rieger1, Richard J Allen2, Lukas Bystricky3, Yuzhou Chen4, Glen Wright Colopy5, Yifan Cui6, Angelica Gonzalez7, Yifei Liu8, R D White9, R A Everett9, H T Banks9, Cynthia J Musante2.   

Abstract

Quantitative systems pharmacology (QSP) models aim to describe mechanistically the pathophysiology of disease and predict the effects of therapies on that disease. For most drug development applications, it is important to predict not only the mean response to an intervention but also the distribution of responses, due to inter-patient variability. Given the necessary complexity of QSP models, and the sparsity of relevant human data, the parameters of QSP models are often not well determined. One approach to overcome these limitations is to develop alternative virtual patients (VPs) and virtual populations (Vpops), which allow for the exploration of parametric uncertainty and reproduce inter-patient variability in response to perturbation. Here we evaluated approaches to improve the efficiency of generating Vpops. We aimed to generate Vpops without sacrificing diversity of the VPs' pathophysiologies and phenotypes. To do this, we built upon a previously published approach (Allen et al., 2016) by (a) incorporating alternative optimization algorithms (genetic algorithm and Metropolis-Hastings) or alternatively (b) augmenting the optimized objective function. Each method improved the baseline algorithm by requiring significantly fewer plausible patients (precursors to VPs) to create a reasonable Vpop.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acceptance rejection sampling; Genetic algorithm; Global optimization; Mathematical modeling; Metropolis-Hastings; Ordinary differential equations

Mesh:

Year:  2018        PMID: 29902482     DOI: 10.1016/j.pbiomolbio.2018.06.002

Source DB:  PubMed          Journal:  Prog Biophys Mol Biol        ISSN: 0079-6107            Impact factor:   3.667


  23 in total

Review 1.  Translational Quantitative Systems Pharmacology in Drug Development: from Current Landscape to Good Practices.

Authors:  Jane P F Bai; Justin C Earp; Venkateswaran C Pillai
Journal:  AAPS J       Date:  2019-06-03       Impact factor: 4.009

Review 2.  Pharmacodynamic Drug-Drug Interactions.

Authors:  Jin Niu; Robert M Straubinger; Donald E Mager
Journal:  Clin Pharmacol Ther       Date:  2019-04-26       Impact factor: 6.875

3.  Application of different approaches to generate virtual patient populations for the quantitative systems pharmacology model of erythropoiesis.

Authors:  Galina Kolesova; Alexander Stepanov; Galina Lebedeva; Oleg Demin
Journal:  J Pharmacokinet Pharmacodyn       Date:  2022-07-07       Impact factor: 2.410

4.  Global sensitivity analysis in physiologically-based pharmacokinetic/pharmacodynamic models of inhaled and opioids anesthetics and its application to generate virtual populations.

Authors:  Frank Sánchez Restrepo; Alher Mauricio Hernández Valdivieso
Journal:  J Pharmacokinet Pharmacodyn       Date:  2022-05-26       Impact factor: 2.410

5.  Quantitative analysis of variability in an integrated model of human ventricular electrophysiology and β-adrenergic signaling.

Authors:  Jingqi Q X Gong; Monica E Susilo; Anna Sher; Cynthia J Musante; Eric A Sobie
Journal:  J Mol Cell Cardiol       Date:  2020-04-21       Impact factor: 5.000

6.  Modeling is data driven: Use it for successful virtual patient generation.

Authors:  Theodore R Rieger; Richard J Allen; Cynthia J Musante
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-05-02

7.  A Computational Model of Neoadjuvant PD-1 Inhibition in Non-Small Cell Lung Cancer.

Authors:  Mohammad Jafarnejad; Chang Gong; Edward Gabrielson; Imke H Bartelink; Paolo Vicini; Bing Wang; Rajesh Narwal; Lorin Roskos; Aleksander S Popel
Journal:  AAPS J       Date:  2019-06-24       Impact factor: 4.009

8.  Multiscale Agent-Based and Hybrid Modeling of the Tumor Immune Microenvironment.

Authors:  Kerri-Ann Norton; Chang Gong; Samira Jamalian; Aleksander S Popel
Journal:  Processes (Basel)       Date:  2019-01-13       Impact factor: 2.847

9.  A QSP Model for Predicting Clinical Responses to Monotherapy, Combination and Sequential Therapy Following CTLA-4, PD-1, and PD-L1 Checkpoint Blockade.

Authors:  Oleg Milberg; Chang Gong; Mohammad Jafarnejad; Imke H Bartelink; Bing Wang; Paolo Vicini; Rajesh Narwal; Lorin Roskos; Aleksander S Popel
Journal:  Sci Rep       Date:  2019-08-02       Impact factor: 4.379

10.  A Quantitative Systems Pharmacology Model of T Cell Engager Applied to Solid Tumor.

Authors:  Huilin Ma; Hanwen Wang; Richard J Sove; Mohammad Jafarnejad; Chia-Hung Tsai; Jun Wang; Craig Giragossian; Aleksander S Popel
Journal:  AAPS J       Date:  2020-06-12       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.